Definitions in hemophilia: communication from the SSC of the ISTH

By V. Blanchette, Nigel S. Key, R. Ljung, M. Manco‐Johnson, H. Berg, A. Srivastava. Journal of Thrombosis and Haemostasis, 2014

713 citations recorded by the source corpus.

Subfields: Hematology

View Paper: https://www.semanticscholar.org/paper/7e56a1c9e053191d909f789112f12e02ee64ac44

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Guangping Gao
2. Wei Zhan
3. Thomas L. Gallagher
4. Jiang-Hui Wang
5. Dominic J. Gessler

Citations in the corpus

• WFH Guidelines for the Management of Hemophilia, 3rd edition (2020, neutral): “Adapted from Blanchette et al. (2014).”
• Emicizumab Prophylaxis in Hemophilia A with Inhibitors (2017, neutral): “Injection-site reaction 8 (24) 1 (8) 5 (10) 1 (14) 15 (15) Headache 3 (9) 1 (8) 6 (12) 2 (29) 12 (12) Fatigue 3 (9) 1 (8) 2 (4) 0 6 (6) Upper respiratory tract infection 7 (21) 0 2 (4) 0 9 (9) Arthralgia 2 (6) 1 (8) 3 (6) 0 6 (6)”
• Adeno-associated virus as a delivery vector for gene therapy of human diseases (2024, background): “285 This provides clear target levels to achieve partial (>1”